Usted buscó: anaphylactic event (Inglés - Maltés)

anaphylactic
korriment

anaphylactic reaction
reazzjoni anafilattika

anaphylactic reaction*
reazzjoni anafilattiku

anaphylactic reactions thromboembolic events
investigazzjonijiet disturbi respiratorji, toraċiċi u medjastinali disturbi fis- sistema immuni disturbi vaskulari disturbi fil- fwied u fil - marrara

readily available in case of a rare anaphylactic event following the administration of the vaccine.
dejjem ikunu disponibbli fil- każ rari ta ’ ġrajja anafilattika li tista ’ tinqala ’ wara l- amministrazzjoni tal- vaċċin.

appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.
kura medika xierqa u superviżjoni għandha dejjem tkun disponibbli fil-pront f’każ ta’ avveniment anafilattiku rari li jista’ jinqala’ wara l-għoti tal-vaċċin.

appropriate medical treatment and supervision should always be readily available in case of an anaphylactic event or hypersensitivity event following administration of the vaccine.
għandu dejjem ikun hemm kura u superviżjoni medika disponibbli f’każ ta’ okkorrenza anafilattika jew okkorrenza ta’ sensittività eċċessiva wara l-għoti tat-tilqima.

as with most vaccines, appropriate medical treatment and supervision should always be readily available in case of an anaphylactic event following the administration of fluenz.
bħall-biċċa l-kbira tat-tilqim, kura medika u superviżjoni adattata għandhom dejjem ikunu disponibbli fil-pront f’każ ta’ avveniment anafilattiku wara l-għoti ta’ fluenz.

as with all injectable vaccines, appropriate medical treatment and supervision must always be readily available in case of a rare anaphylactic event following administration of the vaccine.
bħall-vaċċini injettabbli l-oħrajn kollha, kura medika u superviżjoni xierqa għandhom dejjem ikunu disponibbli fil-każ ta’ episodju anafilattiku rari wara l-għoti tal-vaċċin.

as with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.
bħal fil-każ tal-vaċċini kollha li jistgħu jiġu injettati, kura u sorveljanza medika xierqa għandhom dejjem ikunu disponibbli għal xi każ rari anafilattiku li jista' jinqala' wara t-tilqima.

au as with all injectable vaccines, app ropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.
bħal fil- każ tal- vaċċini l- oħra kollha li jiġu injettati, kura u sorveljanza medika xierqa għandhom dejjem ikunu disponibbli fil- każ rari ta ’ ġrajja anafilattika li tista ’ tinqala ’ wara l- amministrazzjoni tal - vaċċin. li l

as with most vaccines, appropriate medical treatment and supervision should always be readily available to manage an anaphylactic event or serious hypersensitivity event following the administration of fluenz tetra.
bħall-biċċa l-kbira tat-tilqim, kura medika u superviżjoni adattata għandhom dejjem ikunu disponibbli fil-pront biex jimmaniġġjaw avveniment anafilattiku jew avveniment ta’ sensittività eċċessiva serja wara l-għoti ta’ fluenz tetra.

as with all vaccines, appropriate medical treatment should always be readily available in case of an anaphylactic event following the administration of the vaccine (see section 4.8).
bħal fil-każ ta’ kull tilqim ieħor, kura medika xierqa għandha dejjem tkun disponibbli bil-lest f’każ ta’ anafilassi wara l-għoti tat-tilqima (ara sezzjoni 4.8).

as with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of an anaphylactic event following the administration of the vaccine (see section 4.8).
bħal vaċċini kollha li jistgħu jiġu injettati, il-kura u s-superviżjoni medika adattata għandhom dejjem ikunu disponibbli fil-pront f’każ ta’ avveniment anafilattiku wara l-għoti tal-vaċċin.(ara sezzjoni 4.8)

cases of anaphylactic reaction/shock, including fatal events, have been reported in patients treated with intravenousibandronic acid.
każijiet ta’ reazzjoni/xokk anafilattiku, inkluż avvenimenti fatali, kienu irrappurati f’pazjenti kkurati b’ibandronic acid fil-vini.

cases of anaphylactic reaction/shock, including fatal events, have been reported in patients treated with intravenous ibandronic acid.
każijiet ta’ reazzjoni anafilattika/xokk anafilattika, inkluż avvenimenti fatali, ġew irrapportati f’pazjenti kkurati b’ibandronic acid ġol-vini.